Cost reduction in abdominal CT by weight-adjusted dose

AimTo analyze the influence of contrast dose adjusted by weight vs. fixed contrast dose in the attenuation and cost of abdominal computed tomography (CT).Materials and methodsA randomised, consecutive, parallel group study was conducted in 151 patients (74 men and 77 women, age range 22–67 years), studied with the same CT helical protocol. A dose at 1.75 ml/kg was administered in 101 patients while 50 patients had a fixed dose of 120 ml of same non-ionic contrast material (320 mg/ml). Mean enhancements were measured at right hepatic lobe, superior abdominal aorta and inferior cava vein. Statistical analysis was weight-stratified (<60, 61–70, 71–80 and >81 kg).ResultsAortic attenuation was significantly superior (p < 0.05) in the dose adjusted by weight group than in the fixed dose group. Patients who weighed >61 kg in dose-adjusted group, presented higher hepatic attenuation, being statistically significant in those >81 kg (p < 0.01). In dose-adjusted group, there was a savings of €4.1 per patient in patients weighing <80 kg. In patients weighing >80 kg, there was an over cost of €10.7 per patient.ConclusionsAn injection volume of 1.75 ml/kg offers an optimal diagnostic quality with a global savings of €1.34 per patient.